Homologous recombination (HR) deficiency, tumor BRCA1/2 mutations (tmBRCA) and association with response and outcome following platinum monotherapy in high grade serous ovarian cancer (HGSOC).

File Description SizeFormat 
Homologous recombination-Abstract.docxPublished version15.62 kBMicrosoft WordView/Open
Title: Homologous recombination (HR) deficiency, tumor BRCA1/2 mutations (tmBRCA) and association with response and outcome following platinum monotherapy in high grade serous ovarian cancer (HGSOC).
Authors: Brown, R
Timms, K
Paul, J
Hughes, E
El-Bahrawy, M
Steel, JH
Kalva, S
Liu, X
Wang, Y
Rama, NR
Wilhelm-Benartzi, C
Gutin, A
Lewsley, L-A
Siddiqui, N
Patel, N
Lanchbury, JS
Gabra, H
Stronach, EA
Item Type: Conference Paper
Issue Date: 20-May-2015
Date of Acceptance: 1-May-2015
URI: http://hdl.handle.net/10044/1/53272
DOI: https://dx.doi.org/10.1200/jco.2015.33.15_suppl.5576
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology
Journal / Book Title: Journal of Clinical Oncology
Volume: 33
Issue: 15
Copyright Statement: © 2015 American Society of Clinical Oncology
Conference Name: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer
Keywords: Science & Technology
Life Sciences & Biomedicine
Oncology
1112 Oncology And Carcinogenesis
Oncology & Carcinogenesis
Publication Status: Published
Start Date: 2015-05-29
Finish Date: 2015-06-02
Conference Place: Chicago, IL
Appears in Collections:Division of Surgery
Division of Cancer
Department of Medicine
Faculty of Medicine
Epidemiology, Public Health and Primary Care



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commonsx